Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

p53 stimulant

DRUG CLASS:

p53 stimulant

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

RUNX1 mutation	Acute Myelogenous Leukemia	RUNX1 mutation	Acute Myelogenous Leukemia	BTX-A51 Sensitive: C3 – Early Trials BTX-A51 Sensitive : C3	BTX-A51 Sensitive: C3 – Early Trials BTX-A51 Sensitive : C3
TP53 mutation	Triple Negative Breast Cancer	TP53 mutation	Triple Negative Breast Cancer	COTI-2 Sensitive: D – Preclinical COTI-2 Sensitive : D	COTI-2 Sensitive: D – Preclinical COTI-2 Sensitive : D
TP53 wild-type	Acute Myelogenous Leukemia	TP53 wild-type	Acute Myelogenous Leukemia	thioureidobutyronitrile Sensitive: D – Preclinical thioureidobutyronitrile Sensitive : D	thioureidobutyronitrile Sensitive: D – Preclinical thioureidobutyronitrile Sensitive : D